Revenue · 2020–2025
Tarsus Pharmaceuticals revenue
$451M+146.7% · FY2025
Tarsus Pharmaceuticals (TARS) reported $451M in revenue for fiscal 2025, +146.7% year on year.
Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Tarsus Pharmaceuticals revenue |url=https://companiesranked.com/en/company/tarsus-pharmaceuticals/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Tarsus Pharmaceuticals revenue. CompaniesRanked. https://companiesranked.com/en/company/tarsus-pharmaceuticals/revenueBibTeX
@misc{companiesranked-en-company-tarsus-pharmaceuticals-revenue-2026,
author = {{CompaniesRanked}},
title = {{Tarsus Pharmaceuticals revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/tarsus-pharmaceuticals/revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001819790-26-000019 · February 23, 2026
{{cite web |title=Tarsus Pharmaceuticals revenue — 10-K (0001819790-26-000019) |url=https://www.sec.gov/Archives/edgar/data/1819790/000181979026000019/tars-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-23}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.